nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—TOP2A—Etoposide—germ cell cancer	0.197	0.286	CbGbCtD
Levofloxacin—SLC22A2—Vinblastine—germ cell cancer	0.11	0.159	CbGbCtD
Levofloxacin—SLC22A2—Cisplatin—germ cell cancer	0.101	0.146	CbGbCtD
Levofloxacin—ABCB1—Dactinomycin—germ cell cancer	0.0466	0.0677	CbGbCtD
Levofloxacin—SLC22A6—Methotrexate—germ cell cancer	0.039	0.0567	CbGbCtD
Levofloxacin—CYP3A4—Ifosfamide—germ cell cancer	0.033	0.0479	CbGbCtD
Levofloxacin—CYP1A2—Etoposide—germ cell cancer	0.0301	0.0437	CbGbCtD
Levofloxacin—ABCB1—Vinblastine—germ cell cancer	0.0292	0.0424	CbGbCtD
Levofloxacin—ABCB1—Cisplatin—germ cell cancer	0.0268	0.0389	CbGbCtD
Levofloxacin—ABCB1—Etoposide—germ cell cancer	0.0263	0.0382	CbGbCtD
Levofloxacin—CYP3A4—Vinblastine—germ cell cancer	0.0175	0.0254	CbGbCtD
Levofloxacin—ABCB1—Methotrexate—germ cell cancer	0.0174	0.0252	CbGbCtD
Levofloxacin—CYP3A4—Etoposide—germ cell cancer	0.0158	0.0229	CbGbCtD
Levofloxacin—SLC22A4—Organic cation transport—SLC22A3—germ cell cancer	0.00938	0.161	CbGpPWpGaD
Levofloxacin—SLC22A2—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00646	0.111	CbGpPWpGaD
Levofloxacin—SLC22A4—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00636	0.109	CbGpPWpGaD
Levofloxacin—SLC22A2—Organic cation transport—SLC22A3—germ cell cancer	0.00443	0.076	CbGpPWpGaD
Levofloxacin—SLC22A2—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00371	0.0635	CbGpPWpGaD
Levofloxacin—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00361	0.0618	CbGpPWpGaD
Levofloxacin—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00353	0.0604	CbGpPWpGaD
Levofloxacin—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00301	0.0515	CbGpPWpGaD
Levofloxacin—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00203	0.0347	CbGpPWpGaD
Levofloxacin—TOP2A—Vindesine—Vinblastine—germ cell cancer	0.00171	0.291	CbGdCrCtD
Levofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00129	0.0221	CbGpPWpGaD
Levofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.00127	0.0218	CbGpPWpGaD
Levofloxacin—TOP2A—Vinorelbine—Vinblastine—germ cell cancer	0.00108	0.184	CbGdCrCtD
Levofloxacin—TOP2A—Teniposide—Etoposide—germ cell cancer	0.00108	0.184	CbGdCrCtD
Levofloxacin—TOP2A—Podofilox—Etoposide—germ cell cancer	0.00108	0.184	CbGdCrCtD
Levofloxacin—TOP2A—Vincristine—Vinblastine—germ cell cancer	0.000922	0.157	CbGdCrCtD
Levofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000734	0.0126	CbGpPWpGaD
Levofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000723	0.0124	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—NAT9—germ cell cancer	0.000612	0.0105	CbGpPWpGaD
Levofloxacin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000612	0.0105	CbGpPWpGaD
Levofloxacin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000602	0.0103	CbGpPWpGaD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000588	0.0101	CbGpPWpGaD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000579	0.00991	CbGpPWpGaD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	0.000568	0.00972	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.000473	0.0081	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000456	0.00782	CbGpPWpGaD
Levofloxacin—TOP2A—Gastric Cancer Network 2—MYC—germ cell cancer	0.000448	0.00767	CbGpPWpGaD
Levofloxacin—TOP2A—Gastric Cancer Network 2—TP53—germ cell cancer	0.000368	0.0063	CbGpPWpGaD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000333	0.00571	CbGpPWpGaD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000328	0.00562	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000299	0.00511	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000294	0.00504	CbGpPWpGaD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000278	0.00476	CbGpPWpGaD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000274	0.00469	CbGpPWpGaD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000271	0.00464	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—AVP—germ cell cancer	0.000261	0.00447	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000259	0.00443	CbGpPWpGaD
Levofloxacin—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000235	0.00095	CcSEcCtD
Levofloxacin—Decreased appetite—Bleomycin—germ cell cancer	0.000234	0.000947	CcSEcCtD
Levofloxacin—Visual disturbance—Methotrexate—germ cell cancer	0.000234	0.000946	CcSEcCtD
Levofloxacin—Muscle spasms—Cisplatin—germ cell cancer	0.000234	0.000946	CcSEcCtD
Levofloxacin—Angiopathy—Etoposide—germ cell cancer	0.000232	0.000939	CcSEcCtD
Levofloxacin—Confusional state—Ifosfamide—germ cell cancer	0.000232	0.000939	CcSEcCtD
Levofloxacin—Immune system disorder—Etoposide—germ cell cancer	0.000231	0.000935	CcSEcCtD
Levofloxacin—Mediastinal disorder—Etoposide—germ cell cancer	0.000231	0.000933	CcSEcCtD
Levofloxacin—Pain—Bleomycin—germ cell cancer	0.00023	0.000932	CcSEcCtD
Levofloxacin—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00023	0.000931	CcSEcCtD
Levofloxacin—Oedema—Ifosfamide—germ cell cancer	0.00023	0.000931	CcSEcCtD
Levofloxacin—Chills—Etoposide—germ cell cancer	0.00023	0.000929	CcSEcCtD
Levofloxacin—Vision blurred—Cisplatin—germ cell cancer	0.000229	0.000927	CcSEcCtD
Levofloxacin—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000229	0.000926	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000229	0.000926	CcSEcCtD
Levofloxacin—Asthenia—Vinblastine—germ cell cancer	0.000229	0.000925	CcSEcCtD
Levofloxacin—Infection—Ifosfamide—germ cell cancer	0.000229	0.000925	CcSEcCtD
Levofloxacin—Tremor—Cisplatin—germ cell cancer	0.000228	0.000921	CcSEcCtD
Levofloxacin—Alopecia—Etoposide—germ cell cancer	0.000226	0.000915	CcSEcCtD
Levofloxacin—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000226	0.000914	CcSEcCtD
Levofloxacin—Nervous system disorder—Ifosfamide—germ cell cancer	0.000226	0.000913	CcSEcCtD
Levofloxacin—Ill-defined disorder—Cisplatin—germ cell cancer	0.000226	0.000912	CcSEcCtD
Levofloxacin—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000225	0.000912	CcSEcCtD
Levofloxacin—Anaemia—Cisplatin—germ cell cancer	0.000225	0.000909	CcSEcCtD
Levofloxacin—Skin disorder—Ifosfamide—germ cell cancer	0.000224	0.000904	CcSEcCtD
Levofloxacin—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000223	0.0009	CcSEcCtD
Levofloxacin—Feeling abnormal—Bleomycin—germ cell cancer	0.000222	0.000898	CcSEcCtD
Levofloxacin—Osteoarthritis—Methotrexate—germ cell cancer	0.000222	0.000896	CcSEcCtD
Levofloxacin—Anorexia—Ifosfamide—germ cell cancer	0.000219	0.000887	CcSEcCtD
Levofloxacin—Malaise—Cisplatin—germ cell cancer	0.000219	0.000887	CcSEcCtD
Levofloxacin—Decreased appetite—Dactinomycin—germ cell cancer	0.000218	0.000883	CcSEcCtD
Levofloxacin—Diarrhoea—Vinblastine—germ cell cancer	0.000218	0.000882	CcSEcCtD
Levofloxacin—Dysgeusia—Etoposide—germ cell cancer	0.000218	0.000882	CcSEcCtD
Levofloxacin—Leukopenia—Cisplatin—germ cell cancer	0.000218	0.00088	CcSEcCtD
Levofloxacin—Fatigue—Dactinomycin—germ cell cancer	0.000217	0.000876	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000216	0.0037	CbGpPWpGaD
Levofloxacin—Back pain—Etoposide—germ cell cancer	0.000215	0.000872	CcSEcCtD
Levofloxacin—Hypotension—Ifosfamide—germ cell cancer	0.000215	0.00087	CcSEcCtD
Levofloxacin—Pain—Dactinomycin—germ cell cancer	0.000215	0.000869	CcSEcCtD
Levofloxacin—Muscle spasms—Etoposide—germ cell cancer	0.000214	0.000866	CcSEcCtD
Levofloxacin—Urticaria—Bleomycin—germ cell cancer	0.000214	0.000865	CcSEcCtD
Levofloxacin—Body temperature increased—Bleomycin—germ cell cancer	0.000213	0.000861	CcSEcCtD
Levofloxacin—Dizziness—Vinblastine—germ cell cancer	0.000211	0.000853	CcSEcCtD
Levofloxacin—Mood swings—Methotrexate—germ cell cancer	0.00021	0.000849	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00021	0.000848	CcSEcCtD
Levofloxacin—Ataxia—Methotrexate—germ cell cancer	0.000208	0.000843	CcSEcCtD
Levofloxacin—Myalgia—Cisplatin—germ cell cancer	0.000207	0.000837	CcSEcCtD
Levofloxacin—Feeling abnormal—Dactinomycin—germ cell cancer	0.000207	0.000837	CcSEcCtD
Levofloxacin—Paraesthesia—Ifosfamide—germ cell cancer	0.000207	0.000836	CcSEcCtD
Levofloxacin—Ill-defined disorder—Etoposide—germ cell cancer	0.000207	0.000836	CcSEcCtD
Levofloxacin—Anxiety—Cisplatin—germ cell cancer	0.000206	0.000834	CcSEcCtD
Levofloxacin—Anaemia—Etoposide—germ cell cancer	0.000206	0.000833	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000206	0.000832	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000205	0.000831	CcSEcCtD
Levofloxacin—Dyspnoea—Ifosfamide—germ cell cancer	0.000205	0.00083	CcSEcCtD
Levofloxacin—Somnolence—Ifosfamide—germ cell cancer	0.000205	0.000828	CcSEcCtD
Levofloxacin—Discomfort—Cisplatin—germ cell cancer	0.000205	0.000827	CcSEcCtD
Levofloxacin—Vomiting—Vinblastine—germ cell cancer	0.000203	0.00082	CcSEcCtD
Levofloxacin—Malaise—Etoposide—germ cell cancer	0.000201	0.000812	CcSEcCtD
Levofloxacin—Breast disorder—Methotrexate—germ cell cancer	0.0002	0.00081	CcSEcCtD
Levofloxacin—Vertigo—Etoposide—germ cell cancer	0.0002	0.000809	CcSEcCtD
Levofloxacin—Decreased appetite—Ifosfamide—germ cell cancer	0.0002	0.000809	CcSEcCtD
Levofloxacin—Headache—Vinblastine—germ cell cancer	0.0002	0.000808	CcSEcCtD
Levofloxacin—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.0002	0.000807	CcSEcCtD
Levofloxacin—Leukopenia—Etoposide—germ cell cancer	0.000199	0.000806	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000199	0.000804	CcSEcCtD
Levofloxacin—Body temperature increased—Dactinomycin—germ cell cancer	0.000199	0.000803	CcSEcCtD
Levofloxacin—Abdominal pain—Dactinomycin—germ cell cancer	0.000199	0.000803	CcSEcCtD
Levofloxacin—Fatigue—Ifosfamide—germ cell cancer	0.000198	0.000803	CcSEcCtD
Levofloxacin—Oedema—Cisplatin—germ cell cancer	0.000198	0.000803	CcSEcCtD
Levofloxacin—Anaphylactic shock—Cisplatin—germ cell cancer	0.000198	0.000803	CcSEcCtD
Levofloxacin—Hypersensitivity—Bleomycin—germ cell cancer	0.000198	0.000803	CcSEcCtD
Levofloxacin—Infection—Cisplatin—germ cell cancer	0.000197	0.000797	CcSEcCtD
Levofloxacin—Constipation—Ifosfamide—germ cell cancer	0.000197	0.000796	CcSEcCtD
Levofloxacin—Pain—Ifosfamide—germ cell cancer	0.000197	0.000796	CcSEcCtD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	0.000196	0.00336	CbGpPWpGaD
Levofloxacin—Loss of consciousness—Etoposide—germ cell cancer	0.000196	0.000792	CcSEcCtD
Levofloxacin—Nervous system disorder—Cisplatin—germ cell cancer	0.000195	0.000787	CcSEcCtD
Levofloxacin—Cough—Etoposide—germ cell cancer	0.000194	0.000786	CcSEcCtD
Levofloxacin—Thrombocytopenia—Cisplatin—germ cell cancer	0.000194	0.000786	CcSEcCtD
Levofloxacin—Tachycardia—Cisplatin—germ cell cancer	0.000194	0.000783	CcSEcCtD
Levofloxacin—Asthenia—Bleomycin—germ cell cancer	0.000193	0.000782	CcSEcCtD
Levofloxacin—Skin disorder—Cisplatin—germ cell cancer	0.000193	0.00078	CcSEcCtD
Levofloxacin—Hypertension—Etoposide—germ cell cancer	0.000192	0.000778	CcSEcCtD
Levofloxacin—Hyperhidrosis—Cisplatin—germ cell cancer	0.000192	0.000776	CcSEcCtD
Levofloxacin—Asthma—Methotrexate—germ cell cancer	0.000191	0.000775	CcSEcCtD
Levofloxacin—Pruritus—Bleomycin—germ cell cancer	0.000191	0.000771	CcSEcCtD
Levofloxacin—Feeling abnormal—Ifosfamide—germ cell cancer	0.00019	0.000767	CcSEcCtD
Levofloxacin—Chest pain—Etoposide—germ cell cancer	0.00019	0.000767	CcSEcCtD
Levofloxacin—Eosinophilia—Methotrexate—germ cell cancer	0.00019	0.000767	CcSEcCtD
Levofloxacin—Nausea—Vinblastine—germ cell cancer	0.000189	0.000766	CcSEcCtD
Levofloxacin—Anorexia—Cisplatin—germ cell cancer	0.000189	0.000765	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000188	0.000762	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000188	0.000761	CcSEcCtD
Levofloxacin—Pancreatitis—Methotrexate—germ cell cancer	0.000188	0.000759	CcSEcCtD
Levofloxacin—Discomfort—Etoposide—germ cell cancer	0.000187	0.000758	CcSEcCtD
Levofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	0.000186	0.00318	CbGpPWpGaD
Levofloxacin—Hypotension—Cisplatin—germ cell cancer	0.000185	0.00075	CcSEcCtD
Levofloxacin—Hypersensitivity—Dactinomycin—germ cell cancer	0.000185	0.000749	CcSEcCtD
Levofloxacin—Abdominal discomfort—Methotrexate—germ cell cancer	0.000184	0.000743	CcSEcCtD
Levofloxacin—Confusional state—Etoposide—germ cell cancer	0.000183	0.000741	CcSEcCtD
Levofloxacin—Urticaria—Ifosfamide—germ cell cancer	0.000183	0.00074	CcSEcCtD
Levofloxacin—Body temperature increased—Ifosfamide—germ cell cancer	0.000182	0.000736	CcSEcCtD
Levofloxacin—Abdominal pain—Ifosfamide—germ cell cancer	0.000182	0.000736	CcSEcCtD
Levofloxacin—Pancytopenia—Methotrexate—germ cell cancer	0.000182	0.000736	CcSEcCtD
Levofloxacin—Anaphylactic shock—Etoposide—germ cell cancer	0.000182	0.000735	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000181	0.000731	CcSEcCtD
Levofloxacin—Infection—Etoposide—germ cell cancer	0.000181	0.000731	CcSEcCtD
Levofloxacin—Asthenia—Dactinomycin—germ cell cancer	0.00018	0.000729	CcSEcCtD
Levofloxacin—Neutropenia—Methotrexate—germ cell cancer	0.000179	0.000724	CcSEcCtD
Levofloxacin—Dysuria—Methotrexate—germ cell cancer	0.000179	0.000724	CcSEcCtD
Levofloxacin—Paraesthesia—Cisplatin—germ cell cancer	0.000178	0.000721	CcSEcCtD
Levofloxacin—Thrombocytopenia—Etoposide—germ cell cancer	0.000178	0.00072	CcSEcCtD
Levofloxacin—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000178	0.00072	CcSEcCtD
Levofloxacin—Tachycardia—Etoposide—germ cell cancer	0.000177	0.000718	CcSEcCtD
Levofloxacin—Dyspnoea—Cisplatin—germ cell cancer	0.000177	0.000716	CcSEcCtD
Levofloxacin—Skin disorder—Etoposide—germ cell cancer	0.000177	0.000714	CcSEcCtD
Levofloxacin—Erectile dysfunction—Methotrexate—germ cell cancer	0.000176	0.000713	CcSEcCtD
Levofloxacin—Hyperhidrosis—Etoposide—germ cell cancer	0.000176	0.000711	CcSEcCtD
Levofloxacin—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000175	0.000707	CcSEcCtD
Levofloxacin—Anorexia—Etoposide—germ cell cancer	0.000173	0.000701	CcSEcCtD
Levofloxacin—Decreased appetite—Cisplatin—germ cell cancer	0.000172	0.000698	CcSEcCtD
Levofloxacin—Diarrhoea—Dactinomycin—germ cell cancer	0.000172	0.000695	CcSEcCtD
Levofloxacin—Pneumonia—Methotrexate—germ cell cancer	0.000172	0.000695	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000171	0.000693	CcSEcCtD
Levofloxacin—Vomiting—Bleomycin—germ cell cancer	0.000171	0.000693	CcSEcCtD
Levofloxacin—Infestation—Methotrexate—germ cell cancer	0.000171	0.000691	CcSEcCtD
Levofloxacin—Drowsiness—Methotrexate—germ cell cancer	0.000171	0.000691	CcSEcCtD
Levofloxacin—Infestation NOS—Methotrexate—germ cell cancer	0.000171	0.000691	CcSEcCtD
Levofloxacin—Hypotension—Etoposide—germ cell cancer	0.00017	0.000687	CcSEcCtD
Levofloxacin—Rash—Bleomycin—germ cell cancer	0.00017	0.000687	CcSEcCtD
Levofloxacin—Pain—Cisplatin—germ cell cancer	0.00017	0.000686	CcSEcCtD
Levofloxacin—Dermatitis—Bleomycin—germ cell cancer	0.00017	0.000686	CcSEcCtD
Levofloxacin—Hypersensitivity—Ifosfamide—germ cell cancer	0.00017	0.000686	CcSEcCtD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000169	0.0029	CbGpPWpGaD
Levofloxacin—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000169	0.000685	CcSEcCtD
Levofloxacin—Renal failure—Methotrexate—germ cell cancer	0.000168	0.000679	CcSEcCtD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000167	0.00286	CbGpPWpGaD
Levofloxacin—Stomatitis—Methotrexate—germ cell cancer	0.000166	0.000673	CcSEcCtD
Levofloxacin—Conjunctivitis—Methotrexate—germ cell cancer	0.000166	0.000671	CcSEcCtD
Levofloxacin—Asthenia—Ifosfamide—germ cell cancer	0.000165	0.000668	CcSEcCtD
Levofloxacin—Feeling abnormal—Cisplatin—germ cell cancer	0.000164	0.000661	CcSEcCtD
Levofloxacin—Paraesthesia—Etoposide—germ cell cancer	0.000163	0.00066	CcSEcCtD
Levofloxacin—Pruritus—Ifosfamide—germ cell cancer	0.000163	0.000659	CcSEcCtD
Levofloxacin—Haematuria—Methotrexate—germ cell cancer	0.000163	0.000658	CcSEcCtD
Levofloxacin—Dyspnoea—Etoposide—germ cell cancer	0.000162	0.000656	CcSEcCtD
Levofloxacin—Somnolence—Etoposide—germ cell cancer	0.000162	0.000654	CcSEcCtD
Levofloxacin—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000161	0.000653	CcSEcCtD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	0.000161	0.00276	CbGpPWpGaD
Levofloxacin—Epistaxis—Methotrexate—germ cell cancer	0.000161	0.000651	CcSEcCtD
Levofloxacin—Nausea—Bleomycin—germ cell cancer	0.00016	0.000647	CcSEcCtD
Levofloxacin—Vomiting—Dactinomycin—germ cell cancer	0.00016	0.000646	CcSEcCtD
Levofloxacin—Agranulocytosis—Methotrexate—germ cell cancer	0.000159	0.000644	CcSEcCtD
Levofloxacin—Rash—Dactinomycin—germ cell cancer	0.000158	0.000641	CcSEcCtD
Levofloxacin—Decreased appetite—Etoposide—germ cell cancer	0.000158	0.000639	CcSEcCtD
Levofloxacin—Diarrhoea—Ifosfamide—germ cell cancer	0.000157	0.000637	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000157	0.000635	CcSEcCtD
Levofloxacin—Body temperature increased—Cisplatin—germ cell cancer	0.000157	0.000634	CcSEcCtD
Levofloxacin—Fatigue—Etoposide—germ cell cancer	0.000157	0.000634	CcSEcCtD
Levofloxacin—Constipation—Etoposide—germ cell cancer	0.000155	0.000629	CcSEcCtD
Levofloxacin—Pain—Etoposide—germ cell cancer	0.000155	0.000629	CcSEcCtD
Levofloxacin—Haemoglobin—Methotrexate—germ cell cancer	0.000154	0.000623	CcSEcCtD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000154	0.00263	CbGpPWpGaD
Levofloxacin—Haemorrhage—Methotrexate—germ cell cancer	0.000153	0.00062	CcSEcCtD
Levofloxacin—Hepatitis—Methotrexate—germ cell cancer	0.000153	0.00062	CcSEcCtD
Levofloxacin—Dizziness—Ifosfamide—germ cell cancer	0.000152	0.000616	CcSEcCtD
Levofloxacin—Pharyngitis—Methotrexate—germ cell cancer	0.000152	0.000615	CcSEcCtD
Levofloxacin—Urinary tract disorder—Methotrexate—germ cell cancer	0.000151	0.000612	CcSEcCtD
Levofloxacin—Urethral disorder—Methotrexate—germ cell cancer	0.00015	0.000608	CcSEcCtD
Levofloxacin—Feeling abnormal—Etoposide—germ cell cancer	0.00015	0.000606	CcSEcCtD
Levofloxacin—Nausea—Dactinomycin—germ cell cancer	0.000149	0.000603	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Etoposide—germ cell cancer	0.000149	0.000601	CcSEcCtD
Levofloxacin—Visual impairment—Methotrexate—germ cell cancer	0.000148	0.000597	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	0.000147	0.00251	CbGpPWpGaD
Levofloxacin—Vomiting—Ifosfamide—germ cell cancer	0.000146	0.000592	CcSEcCtD
Levofloxacin—Hypersensitivity—Cisplatin—germ cell cancer	0.000146	0.000591	CcSEcCtD
Levofloxacin—Rash—Ifosfamide—germ cell cancer	0.000145	0.000587	CcSEcCtD
Levofloxacin—Dermatitis—Ifosfamide—germ cell cancer	0.000145	0.000586	CcSEcCtD
Levofloxacin—Erythema multiforme—Methotrexate—germ cell cancer	0.000145	0.000586	CcSEcCtD
Levofloxacin—Urticaria—Etoposide—germ cell cancer	0.000144	0.000584	CcSEcCtD
Levofloxacin—Body temperature increased—Etoposide—germ cell cancer	0.000144	0.000581	CcSEcCtD
Levofloxacin—Abdominal pain—Etoposide—germ cell cancer	0.000144	0.000581	CcSEcCtD
Levofloxacin—Eye disorder—Methotrexate—germ cell cancer	0.000143	0.000579	CcSEcCtD
Levofloxacin—Tinnitus—Methotrexate—germ cell cancer	0.000143	0.000578	CcSEcCtD
Levofloxacin—Asthenia—Cisplatin—germ cell cancer	0.000142	0.000576	CcSEcCtD
Levofloxacin—Cardiac disorder—Methotrexate—germ cell cancer	0.000142	0.000575	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000141	0.00242	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000139	0.00238	CbGpPWpGaD
Levofloxacin—Angiopathy—Methotrexate—germ cell cancer	0.000139	0.000562	CcSEcCtD
Levofloxacin—Immune system disorder—Methotrexate—germ cell cancer	0.000138	0.00056	CcSEcCtD
Levofloxacin—Mediastinal disorder—Methotrexate—germ cell cancer	0.000138	0.000559	CcSEcCtD
Levofloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—germ cell cancer	0.000138	0.00236	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000138	0.00236	CbGpPWpGaD
Levofloxacin—Chills—Methotrexate—germ cell cancer	0.000138	0.000556	CcSEcCtD
Levofloxacin—Nausea—Ifosfamide—germ cell cancer	0.000137	0.000553	CcSEcCtD
Levofloxacin—Diarrhoea—Cisplatin—germ cell cancer	0.000136	0.000549	CcSEcCtD
Levofloxacin—Alopecia—Methotrexate—germ cell cancer	0.000135	0.000548	CcSEcCtD
Levofloxacin—Mental disorder—Methotrexate—germ cell cancer	0.000134	0.000543	CcSEcCtD
Levofloxacin—Hypersensitivity—Etoposide—germ cell cancer	0.000134	0.000542	CcSEcCtD
Levofloxacin—Malnutrition—Methotrexate—germ cell cancer	0.000133	0.00054	CcSEcCtD
Levofloxacin—Erythema—Methotrexate—germ cell cancer	0.000133	0.00054	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—H2AFZ—germ cell cancer	0.000131	0.00224	CbGpPWpGaD
Levofloxacin—Dysgeusia—Methotrexate—germ cell cancer	0.000131	0.000528	CcSEcCtD
Levofloxacin—Asthenia—Etoposide—germ cell cancer	0.00013	0.000528	CcSEcCtD
Levofloxacin—Back pain—Methotrexate—germ cell cancer	0.000129	0.000522	CcSEcCtD
Levofloxacin—Pruritus—Etoposide—germ cell cancer	0.000129	0.00052	CcSEcCtD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000128	0.0022	CbGpPWpGaD
Levofloxacin—Vomiting—Cisplatin—germ cell cancer	0.000126	0.00051	CcSEcCtD
Levofloxacin—Vision blurred—Methotrexate—germ cell cancer	0.000126	0.000509	CcSEcCtD
Levofloxacin—Rash—Cisplatin—germ cell cancer	0.000125	0.000506	CcSEcCtD
Levofloxacin—Dermatitis—Cisplatin—germ cell cancer	0.000125	0.000506	CcSEcCtD
Levofloxacin—Diarrhoea—Etoposide—germ cell cancer	0.000124	0.000503	CcSEcCtD
Levofloxacin—Ill-defined disorder—Methotrexate—germ cell cancer	0.000124	0.000501	CcSEcCtD
Levofloxacin—Anaemia—Methotrexate—germ cell cancer	0.000123	0.000499	CcSEcCtD
Levofloxacin—Malaise—Methotrexate—germ cell cancer	0.00012	0.000487	CcSEcCtD
Levofloxacin—Dizziness—Etoposide—germ cell cancer	0.00012	0.000486	CcSEcCtD
Levofloxacin—Vertigo—Methotrexate—germ cell cancer	0.00012	0.000485	CcSEcCtD
Levofloxacin—Leukopenia—Methotrexate—germ cell cancer	0.000119	0.000483	CcSEcCtD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000118	0.00202	CbGpPWpGaD
Levofloxacin—Nausea—Cisplatin—germ cell cancer	0.000118	0.000477	CcSEcCtD
Levofloxacin—Cough—Methotrexate—germ cell cancer	0.000116	0.000471	CcSEcCtD
Levofloxacin—Vomiting—Etoposide—germ cell cancer	0.000116	0.000468	CcSEcCtD
Levofloxacin—Rash—Etoposide—germ cell cancer	0.000115	0.000464	CcSEcCtD
Levofloxacin—Dermatitis—Etoposide—germ cell cancer	0.000115	0.000463	CcSEcCtD
Levofloxacin—Headache—Etoposide—germ cell cancer	0.000114	0.000461	CcSEcCtD
Levofloxacin—Myalgia—Methotrexate—germ cell cancer	0.000114	0.000459	CcSEcCtD
Levofloxacin—Chest pain—Methotrexate—germ cell cancer	0.000114	0.000459	CcSEcCtD
Levofloxacin—Arthralgia—Methotrexate—germ cell cancer	0.000114	0.000459	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000113	0.000456	CcSEcCtD
Levofloxacin—Discomfort—Methotrexate—germ cell cancer	0.000112	0.000454	CcSEcCtD
Levofloxacin—Confusional state—Methotrexate—germ cell cancer	0.00011	0.000444	CcSEcCtD
Levofloxacin—Anaphylactic shock—Methotrexate—germ cell cancer	0.000109	0.00044	CcSEcCtD
Levofloxacin—Infection—Methotrexate—germ cell cancer	0.000108	0.000438	CcSEcCtD
Levofloxacin—Nausea—Etoposide—germ cell cancer	0.000108	0.000437	CcSEcCtD
Levofloxacin—Nervous system disorder—Methotrexate—germ cell cancer	0.000107	0.000432	CcSEcCtD
Levofloxacin—Thrombocytopenia—Methotrexate—germ cell cancer	0.000107	0.000431	CcSEcCtD
Levofloxacin—Skin disorder—Methotrexate—germ cell cancer	0.000106	0.000428	CcSEcCtD
Levofloxacin—Hyperhidrosis—Methotrexate—germ cell cancer	0.000105	0.000426	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	0.000105	0.00179	CbGpPWpGaD
Levofloxacin—Anorexia—Methotrexate—germ cell cancer	0.000104	0.00042	CcSEcCtD
Levofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	0.000102	0.00175	CbGpPWpGaD
Levofloxacin—Hypotension—Methotrexate—germ cell cancer	0.000102	0.000412	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Methotrexate—germ cell cancer	9.92e-05	0.000401	CcSEcCtD
Levofloxacin—Insomnia—Methotrexate—germ cell cancer	9.85e-05	0.000398	CcSEcCtD
Levofloxacin—Paraesthesia—Methotrexate—germ cell cancer	9.78e-05	0.000395	CcSEcCtD
Levofloxacin—Dyspnoea—Methotrexate—germ cell cancer	9.71e-05	0.000393	CcSEcCtD
Levofloxacin—Somnolence—Methotrexate—germ cell cancer	9.68e-05	0.000392	CcSEcCtD
Levofloxacin—Dyspepsia—Methotrexate—germ cell cancer	9.59e-05	0.000388	CcSEcCtD
Levofloxacin—Decreased appetite—Methotrexate—germ cell cancer	9.47e-05	0.000383	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Methotrexate—germ cell cancer	9.4e-05	0.00038	CcSEcCtD
Levofloxacin—Fatigue—Methotrexate—germ cell cancer	9.39e-05	0.00038	CcSEcCtD
Levofloxacin—Pain—Methotrexate—germ cell cancer	9.31e-05	0.000377	CcSEcCtD
Levofloxacin—Feeling abnormal—Methotrexate—germ cell cancer	8.97e-05	0.000363	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Methotrexate—germ cell cancer	8.9e-05	0.00036	CcSEcCtD
Levofloxacin—Urticaria—Methotrexate—germ cell cancer	8.65e-05	0.00035	CcSEcCtD
Levofloxacin—Body temperature increased—Methotrexate—germ cell cancer	8.61e-05	0.000348	CcSEcCtD
Levofloxacin—Abdominal pain—Methotrexate—germ cell cancer	8.61e-05	0.000348	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	8.59e-05	0.00147	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	8.58e-05	0.00147	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—TP53—germ cell cancer	8.24e-05	0.00141	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Methotrexate—germ cell cancer	8.02e-05	0.000324	CcSEcCtD
Levofloxacin—Asthenia—Methotrexate—germ cell cancer	7.81e-05	0.000316	CcSEcCtD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—AVP—germ cell cancer	7.81e-05	0.00134	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	7.72e-05	0.00132	CbGpPWpGaD
Levofloxacin—Pruritus—Methotrexate—germ cell cancer	7.7e-05	0.000312	CcSEcCtD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	7.6e-05	0.0013	CbGpPWpGaD
Levofloxacin—Diarrhoea—Methotrexate—germ cell cancer	7.45e-05	0.000301	CcSEcCtD
Levofloxacin—Dizziness—Methotrexate—germ cell cancer	7.2e-05	0.000291	CcSEcCtD
Levofloxacin—Vomiting—Methotrexate—germ cell cancer	6.92e-05	0.00028	CcSEcCtD
Levofloxacin—Rash—Methotrexate—germ cell cancer	6.87e-05	0.000278	CcSEcCtD
Levofloxacin—Dermatitis—Methotrexate—germ cell cancer	6.86e-05	0.000277	CcSEcCtD
Levofloxacin—Headache—Methotrexate—germ cell cancer	6.82e-05	0.000276	CcSEcCtD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	6.74e-05	0.00115	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—SLC2A3—germ cell cancer	6.61e-05	0.00113	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—SLC22A3—germ cell cancer	6.52e-05	0.00112	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—AVP—germ cell cancer	6.51e-05	0.00112	CbGpPWpGaD
Levofloxacin—Nausea—Methotrexate—germ cell cancer	6.47e-05	0.000262	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—CRABP1—germ cell cancer	5.31e-05	0.00091	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	5.2e-05	0.000891	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—germ cell cancer	5.06e-05	0.000867	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—HRAS—germ cell cancer	4.77e-05	0.000817	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—MYC—germ cell cancer	4.53e-05	0.000775	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—TP53—germ cell cancer	3.72e-05	0.000637	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—HRAS—germ cell cancer	3.65e-05	0.000626	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SLC2A3—germ cell cancer	3.61e-05	0.000619	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SLC22A3—germ cell cancer	3.56e-05	0.00061	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	3.56e-05	0.000609	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	3.44e-05	0.00059	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CRABP1—germ cell cancer	2.9e-05	0.000497	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SLC2A3—germ cell cancer	2.88e-05	0.000494	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SLC22A3—germ cell cancer	2.84e-05	0.000487	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	2.83e-05	0.000484	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CRABP1—germ cell cancer	2.32e-05	0.000397	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SLC2A3—germ cell cancer	2.23e-05	0.000381	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SLC22A3—germ cell cancer	2.19e-05	0.000376	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CRABP1—germ cell cancer	1.79e-05	0.000306	CbGpPWpGaD
